两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova Therapeutics, Inc.(ONTX)$ 8-K - Current report Filed: 2018-02-06 AccNo: 0001104659-18-006626 Size: 21 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2018-01-30 AccNo: 0001104659-18-004884 Size: 640 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ 8-K - Current report Filed: 2018-01-30 AccNo: 0001104659-18-004882 Size: 3 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ CORRESP [Cover] - Correspondence Filed: 2017-12-27 AccNo: 0001104659-17-075210 Size: 9 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-12-04 AccNo: 0000000000-17-042420 Size: 47 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ 8-K - Current report Filed: 2018-01-17 AccNo: 0001104659-18-002634 Size: 68 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-09 AccNo: 0001535610-18-000039 Size: 15 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-01-03 AccNo: 0001104659-18-000554 Size: 108 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2017-12-29 AccNo: 0001104659-17-075718 Size: 439 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2017-12-29 AccNo: 0001104659-17-075718 Size: 439 KB 网页链接